Episode Details

A federal judge in Louisiana has temporarily halted the states lawsuit aiming to block nationwide mail delivery of the abortion pill mifepristone. The judge, a Trump appointee, denied Louisianas request for an immediate stop but ordered the case to wait for the FDAs evidence-based review to conclude. The FDA first approved mifepristone in 2000, and its now used in 60% of U.S. abortions. Since the Supreme Court overturned Roe v. Wade in 2022, nearly half the states have restricted abortion access, increasing demand for medication options like mifepristone and misoprostol up to ten weeks. Louisianas Republican attorney general plans to appeal to the fifth circuit, while five other red states are pursuing broader challenges to the drugs approval and rules. The FDA review is ongoing, with potential implications for the midterms.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/a4e2498551db904c